Bayer added more punch to its global commitment to get 100 million women and girls improved access to contraceptives by the end of the decade by pledging $464 million (€400 million) toward upgrading and building manufacturing facilities.
The investment is aimed at improving production sites in Turku, Finland, and building a new facility in Alajuela, Costa Rica, the company said.
“By giving women the chance to determine their own future, access to family planning enables them to raise healthier families and to make an even greater economic contribution,” Matthias Berninger, a Bayer senior vice president, said in a statement.